Histogen Inc (HSTO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Short interest in Histogen Inc COM NEW (OTC:HSTO) decreased during the last reporting period, falling from 1.12K to 1.12K. This put 0.03% of the company's publicly available shares short. Short ...

Immune-focused biotech firm Histogen (NASDAQ:HSTO) said on Monday that it had decided to liquidate after failing to find any viable strategic alternatives. Shares of HSTO fell 6.2% in extended trading ...

On Friday, shares of Histogen Inc HSTO experienced volatile short activity. After the activity, the stock price went up +54.24% to $1.33. The overall sentiment for HSTO has been Bullish. The signal ...